Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $313.27M.
ENTERPRISE VALUE (EV)
$313.27M
Atea Pharmaceuticals, Inc.
Market Cap
$408.14M
Enterprise Value (EV)
$313.27M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | $408.14M | $313.27M |
| Carlsmed, Inc. (CARL)vs › | $412.76M | $388.43M |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $411.45M | $520.66M |
| Shoulder Innovations, Inc. (SI)vs › | $408.54M | $398.93M |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $398.49M | $229.94M |
| Editas Medicine, Inc. (EDIT)vs › | $432.00M | $265.69M |
| Capricor Therapeutics, Inc. (CAPR)vs › | $434.84M | $504.95M |
| MapLight Therapeutics, Inc. (MPLT)vs › | $389.14M | $319.50M |
| Assembly Biosciences, Inc. (ASMB)vs › | $443.61M | $413.67M |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $378.75M | $379.95M |
Market Cap
$408.14M
Total Debt
$843000.00
Cash
$95.71M
Enterprise Value
$313.27M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
